Polymeric nanocarriers for drug delivery in osteosarcoma treatment

X Gu, J Ding, Z Zhang, Q Li, X Zhuang… - Current …, 2015 - ingentaconnect.com
Osteosarcoma (OS) is one of the most serious malignancies along with a high incidence in
children and teenagers. Although the neoadjuvant chemotherapy of OS has made great …

[HTML][HTML] Recent advances of drug delivery nanocarriers in osteosarcoma treatment

SY Wang, HZ Hu, XC Qing, ZC Zhang… - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
Osteosarcoma is the most common primary malignant bone tumor mainly occurred in
children and adolescence, and chemotherapy is limited for the side effects and development …

[HTML][HTML] Drug delivery nanocarriers and recent advances ventured to improve therapeutic efficacy against osteosarcoma: an overview

SA Desai, A Manjappa, P Khulbe - Journal of the Egyptian National …, 2021 - Springer
Background Osteosarcoma (OS) is one of the key cancers affecting the bone tissues,
primarily occurred in children and adolescence. Recently, chemotherapy followed by …

[HTML][HTML] Nanosized drug delivery strategies in osteosarcoma chemotherapy

C Chen, S Wang, J Wang, F Yao, X Tang… - APL bioengineering, 2023 - pubs.aip.org
Despite recent developments worldwide in the therapeutic care of osteosarcoma (OS), the
ongoing challenges in overcoming limitations and side effects of chemotherapy drugs …

Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma-an updated review

S Ashique, M Faiyazuddin, O Afzal, S Gowri… - Journal of Drug Delivery …, 2023 - Elsevier
Osteosarcoma could be a sort of threatening tumor that starts in a bone and spreads to
adjoining bone cells. Among the different sorts of bone malignancies, osteosarcoma is the …

Surface engineering of nanoparticles with ligands for targeted delivery to osteosarcoma

X Huang, W Wu, W Yang, X Qing, Z Shao - Colloids and Surfaces B …, 2020 - Elsevier
Osteosarcoma is one of the most common malignant bone tumors which affect adolescents.
Neoadjuvant chemotherapy followed by operation has become recommended for …

Nanocarrier-based drug delivery systems for bone cancer therapy: a review

SR Prasad, TSS Kumar, A Jayakrishnan - Biomedical Materials, 2021 - iopscience.iop.org
Bone cancer is a malignant tumor that originates in the bone and destroys the healthy bone
tissues. Of the various types of bone tumors, osteosarcoma is the most commonly diagnosed …

[HTML][HTML] Advanced nanoscale drug delivery systems for bone cancer therapy

N Amiryaghoubi, M Fathi, J Barar, H Omidian… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Bone tumors are relatively rare, which are complex cancers and primarily involve the long
bones and pelvis. Bone cancer is mainly categorized into osteosarcoma (OS) …

Research progress of nanomaterials in chemotherapy of osteosarcoma

T Yu, Z Cai, X Chang, C Xing, S White… - Orthopaedic …, 2023 - Wiley Online Library
Osteosarcoma (OS) is a common malignant bone tumor that occurs mostly in children and
adolescents. At present, surgery after chemotherapy or postoperative adjuvant …

[HTML][HTML] Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics

P Shi, Z Cheng, K Zhao, Y Chen, A Zhang… - Journal of …, 2023 - Springer
Osteosarcoma, the most common malignant tumor of the bone, seriously influences people's
lives and increases their economic burden. Conventional chemotherapy drugs achieve …